Lv61
1610 积分 2022-10-31 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
3小时前
已完结
TACI is required for the survival of short- and long-lived plasma cells
9天前
已完结
New biological agents in systemic lupus erythematosus
2个月前
已完结
The BAFF/APRIL system in SLE pathogenesis
2个月前
已完结
Autoantibodies in neurological disease
3个月前
已完结
Targeting cytokine networks in neuroinflammatory diseases
3个月前
已完结
Neuroinflammation across neurological diseases
3个月前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
3个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
5个月前
已完结
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
5个月前
已完结
皖公网安备34019202002308
